BerandaPTCT • NASDAQ
add
PTC Therapeutics, Inc.
Tutup sebelumnya
$77,85
Rentang hari
$76,54 - $78,68
Rentang tahun
$35,95 - $87,50
Kapitalisasi pasar
6,20 M USD
Volume Rata-Rata
1,92 jt
Rasio P/E
9,25
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 211,01 jt | 7,23% |
Biaya operasional | 91,58 jt | 19,72% |
Penghasilan bersih | 15,90 jt | 114,90% |
Margin laba bersih | 7,53 | 113,89% |
Penghasilan per saham | 0,19 | 113,79% |
EBITDA | 14,60 jt | 132,10% |
Tarif pajak efektif | 168,89% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,71 M | 66,83% |
Total aset | 2,64 M | 43,50% |
Total liabilitas | 2,80 M | -3,35% |
Total ekuitas | -155,76 jt | — |
Saham yang beredar | 80,29 jt | — |
Harga terhadap nilai buku | -39,92 | — |
Tingkat pengembalian aset | 0,33% | — |
Tingkat pengembalian modal | 0,38% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 15,90 jt | 114,90% |
Kas dari operasi | -66,30 jt | 13,89% |
Kas dari investasi | -289,62 jt | -578,67% |
Kas dari pembiayaan | 15,22 jt | 186,34% |
Perubahan kas bersih | -346,77 jt | -169,33% |
Arus kas bebas | -326,80 jt | -599,26% |
Tentang
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Didirikan
1 Jan 1998
Kantor pusat
Situs
Karyawan
939
